* Analyses conclude that Xarelto clinical trial results were
not affected by Alere’s faulty monitoring device INRatio
The post BRIEF-FDA concludes Xarelto clinical trial results not affected by Alere’s INRatio appeared first on NASDAQ.
BRIEF-FDA concludes Xarelto clinical trial results not affected by Alere’s INRatio
